Taysha Gene Therapies, Inc. (TSHA)
4.70
-0.09
(-1.88%)
USD |
NASDAQ |
Feb 20, 16:00
4.695
0.00 (0.00%)
After-Hours: 20:00
Taysha Gene Therapies Price : 4.70 for Feb. 20, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Neurogene, Inc. | 17.64 |
| ACADIA Pharmaceuticals, Inc. | 23.99 |
| Agenus, Inc. | 3.06 |
| Alnylam Pharmaceuticals, Inc. | 336.19 |
| Savara, Inc. | 5.53 |
Price Related Metrics
| PS Ratio | 209.59 |
| PEG Ratio | -0.014 |
| Price to Book Value | 5.879 |
| Earnings Yield | -7.54% |
| Market Cap | 1.287B |
| PEGY Ratio | -0.014 |